U.S. supplement brands are entering a new phase in 2026: AI can accelerate planning, formula screening, and documentation, but governance determines whether speed turns into compliant growth.
Recent industry reporting shows more brands adopting AI-assisted decision workflows. The practical lesson for OEM partnerships is simple: AI can support preparation, but final decisions on claims, specifications, and release must stay with qualified human teams.